Genetic associations between voltage-gated calcium channels and psychiatric disorders

A Andrade, A Brennecke, S Mallat, J Brown… - International journal of …, 2019 - mdpi.com
Psychiatric disorders are mental, behavioral or emotional disorders. These conditions are
prevalent, one in four adults suffer from any type of psychiatric disorders world-wide. It has …

Genetic variants in major depressive disorder: from pathophysiology to therapy

X Gonda, P Petschner, N Eszlari, D Baksa… - Pharmacology & …, 2019 - Elsevier
In spite of promising preclinical results there is a decreasing number of new registered
medications in major depression. The main reason behind this fact is the lack of confirmation …

Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with …

EM Wigmore, JD Hafferty, LS Hall… - The …, 2020 - nature.com
Antidepressants demonstrate modest response rates in the treatment of major depressive
disorder (MDD). Despite previous genome-wide association studies (GWAS) of …

Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients

S Bhattacharyya, AT Ahmed, M Arnold, D Liu… - Translational …, 2019 - nature.com
Metabolomics provides valuable tools for the study of drug effects, unraveling the
mechanism of action and variation in response due to treatment. In this study we used …

Can Machine Learning help us in dealing with treatment resistant depression? A review

A Pigoni, G Delvecchio, D Madonna, C Bressi… - Journal of Affective …, 2019 - Elsevier
Background About one third of patients treated with antidepressant do not show sufficient
symptoms relief and up to 15% of patients remain symptomatic even after multiple trials are …

Pharmacogenetics in psychiatry

F Corponi, C Fabbri, A Serretti - Advances in Pharmacology, 2018 - Elsevier
Mental illness represents a major health issue both at the individual and at the
socioeconomical level. This is partly due to the current suboptimal treatment options …

The genetics of treatment-resistant depression: a critical review and future perspectives

C Fabbri, F Corponi, D Souery, S Kasper… - International Journal …, 2019 - academic.oup.com
Background One-third of depressed patients develop treatment-resistant depression with the
related sequelae in terms of poor functionality and worse prognosis. Solid evidence …

[HTML][HTML] Pharmacogenetics and depression: a critical perspective

F Corponi, C Fabbri, A Serretti - Psychiatry investigation, 2019 - ncbi.nlm.nih.gov
Depression leads the higher personal and socio-economical burden within psychiatric
disorders. Despite the fact that over 40 antidepressants (ADs) are available, suboptimal …

Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance

C Fabbri, F Corponi, D Albani, I Raimondi… - Progress in Neuro …, 2018 - Elsevier
A candidate gene and a genome-wide approach were combined to study the
pharmacogenetics of antidepressant response and resistance. Investigated genes were …

Targeted exome sequencing identifies five novel loci at genome-wide significance for modulating antidepressant response in patients with major depressive disorder

Z Xu, C Xie, L Xia, Y Yuan, H Zhu, X Huang, C Li… - Translational …, 2020 - nature.com
In order to determine the role of single nucleotide variants (SNVs) in modulating
antidepressant response, we conducted a study, consisting of 929 major depressive …